Advances in Critical Care of the Pediatric Hematopoietic Stem Cell Transplant Patient

Pediatric Clinics of North America

Volumn 60, Issue 3, 2013, Pages 689-707

  Chima, Ranjit S ^a,b   Abulebda, Kamal ^a   Jodele, Sonata ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

BMT; Mechanical ventilation; Outcomes; Pediatrics; Respiratory failure; Stem cell transplant

Indexed keywords

ABATACEPT; ACICLOVIR; ALEMTUZUMAB; AMPHOTERICIN B; BASILIXIMAB; BLEOMYCIN; BUSULFAN; CASPOFUNGIN; CIDOFOVIR; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; LEFLUNOMIDE; METHOTREXATE; MICAFUNGIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTAMIDINE; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; UNINDEXED DRUG; VALACICLOVIR; VORICONAZOLE;

ACUTE LUNG INJURY; ADENOVIRUS INFECTION; ARTIFICIAL VENTILATION; ASPERGILLOSIS; CANDIDIASIS; CHILD; CRITICALLY ILL PATIENT; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; EPSTEIN BARR VIRUS INFECTION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HERPES VIRUS INFECTION; HERPES ZOSTER; HUMAN; INFECTION; INTENSIVE CARE; KIDNEY INJURY; LUNG HEMORRHAGE; LUNG INJURY; MORBIDITY; MORTALITY; MYCOSIS; NEUROLOGICAL COMPLICATION; PNEUMOCYSTIS PNEUMONIA; POLYOMAVIRUS INFECTION; PROGNOSIS; RESPIRATORY FAILURE; REVIEW; TREATMENT INDICATION;

EID: 84877062899     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2013.02.007     Document Type: Review

References (96)

1. van Gestel J.P., Bollen C.W., van der Tweel I., et al. Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression analysis. Crit Care Med 2008, 36(10):2898-2904.
2. Chima R.S., Daniels R.C., Kim M.O., et al. Improved outcomes for stem cell transplant recipients requiring pediatric intensive care. Pediatr Crit Care Med 2012, 13(6):e336-e342.
3. van Gestel J.P., Bollen C.W., Bierings M.B., et al. Survival in a recent cohort of mechanically ventilated pediatric allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2008, 14(12):1385-1393.
4. Cole T.S., Johnstone I.C., Pearce M.S., et al. Outcome of children requiring intensive care following haematopoietic SCT for primary immunodeficiency and other non-malignant disorders. Bone Marrow Transplant 2012, 47(1):40-45.
5. Aspesberro F., Guthrie K.A., Woolfrey A.E., et al. Outcome of pediatric hematopoietic stem cell transplant recipients requiring mechanical ventilation. J Intensive Care Med 2012, [Epub ahead of print].
6. Haspel R.L., Miller K.B. Hematopoietic stem cells: source matters. Curr Stem Cell Res Ther 2008, 3(4):229-236.
7. Gallardo D., de la Camara R., Nieto J.B., et al. Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study. Haematologica 2009, 94(9):1282-1288.
8. Jacobsohn D.A., Duerst R., Tse W., et al. Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. Lancet 2004, 364(9429):156-162.
9. Bakken A.M. Cryopreserving human peripheral blood progenitor cells. Curr Stem Cell Res Ther 2006, 1(1):47-54.
10. Hunt C.J. Cryopreservation of human stem cells for clinical application: a review. Transfus Med Hemother 2011, 38(2):107-123.
11. van Burik J.A., Weisdorf D.J. Infections in recipients of blood and marrow transplantation. Hematol Oncol Clin North Am 1999, 13(5):1065-1089. viii.
12. Lujan-Zibermann J. Infections in hematopoietic stem cell transplant recipients. Principles and practice of pediatric infectious diseases 2009, 558-562. Elsevier, Philadelphia. S.L. Long (Ed.).
13. Storek J., Geddes M., Khan F., et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 2008, 30(4):425-437.
14. Oliveira K., Brecher S.M., Durbin A., et al. Direct identification of Staphylococcus aureus from positive blood culture bottles. J Clin Microbiol 2003, 41(2):889-891.
15. Fujita Y., Rooney C.M., Heslop H.E. Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant 2008, 41(2):193-198.
16. Leen A.M., Heslop H.E. Cytotoxic T lymphocytes as immune-therapy in haematological practice. Br J Haematol 2008, 143(2):169-179.
17. Segal B.H., Almyroudis N.G., Battiwalla M., et al. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clin Infect Dis 2007, 44(3):402-409.
18. Michelson P.H., Goyal R., Kurland G. Pulmonary complications of haematopoietic cell transplantation in children. Paediatr Respir Rev 2007, 8(1):46-61.
19. Kaya Z., Weiner D.J., Yilmaz D., et al. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children. Biol Blood Marrow Transplant 2009, 15(7):817-826.
20. Panoskaltsis-Mortari A., Griese M., Madtes D.K., et al. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med 2011, 183(9):1262-1279.
21. Keates-Baleeiro J., Moore P., Koyama T., et al. Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients. Bone Marrow Transplant 2006, 38(4):285-289.
22. Kantrow S.P., Hackman R.C., Boeckh M., et al. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 1997, 63(8):1079-1086.
23. Fukuda T., Hackman R.C., Guthrie K.A., et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003, 102(8):2777-2785.
24. Afessa B., Litzow M.R., Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001, 28(5):425-434.
25. Cooke K.R. Acute lung injury after allogeneic stem cell transplantation: from the clinic, to the bench and back again. Pediatr Transplant 2005, 9(Suppl 7):25-36.
26. Yanik G.A., Ho V.T., Levine J.E., et al. The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood 2008, 112(8):3073-3081.
27. Cooke K.R., Hill G.R., Gerbitz A., et al. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 2000, 70(2):272-279.
28. Jodele S., Hirsch R., Laskin B., et al. Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Biol Blood Marrow Transplant 2013, 19(2):202-207.
29. Bunte M.C., Patnaik M.M., Pritzker M.R., et al. Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction. Bone Marrow Transplant 2008, 41(8):677-686.
30. Heggen J., West C., Olson E., et al. Diffuse alveolar hemorrhage in pediatric hematopoietic cell transplant patients. Pediatrics 2002, 109(5):965-971.
31. Afessa B., Tefferi A., Litzow M.R., et al. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002, 166(10):1364-1368.
32. Yanik G., Hellerstedt B., Custer J., et al. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002, 8(7):395-400.
33. DiCarlo J.V., Alexander S.R., Agarwal R., et al. Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol 2003, 25(10):801-805.
34. Elbahlawan L., West N.K., Avent Y., et al. Impact of continuous renal replacement therapy on oxygenation in children with acute lung injury after allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer 2010, 55(3):540-545.
35. Tamburro R.F., Thomas N.J., Pon S., et al. Post hoc analysis of calfactant use in immunocompromised children with acute lung injury: impact and feasibility of further clinical trials. Pediatr Crit Care Med 2008, 9(5):459-464.
36. Gow K.W., Wulkan M.L., Heiss K.F., et al. Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: the Extracorporeal Life Support Organization experience. J Pediatr Surg 2006, 41(4):662-667.
37. Morris S.H., Haight A.E., Kamat P., et al. Successful use of extracorporeal life support in a hematopoietic stem cell transplant patient with diffuse alveolar hemorrhage. Pediatr Crit Care Med 2010, 11(1):e4-e7.
38. Crawford S.W., Hackman R.C. Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis 1993, 147(6 Pt 1):1393-1400.
39. Tamburro R.F., Barfield R.C., Shaffer M.L., et al. Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation. Pediatr Crit Care Med 2008, 9(3):270-277.
40. Gronroos M.H., Bolme P., Winiarski J., et al. Long-term renal function following bone marrow transplantation. Bone Marrow Transplant 2007, 39(11):717-723.
41. Hazar V., Gungor O., Guven A.G., et al. Renal function after hematopoietic stem cell transplantation in children. Pediatr Blood Cancer 2009, 53(2):197-202.
42. Kist-van Holthe J.E., van Zwet J.M., Brand R., et al. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 1998, 22(6):559-564.
43. Kist-van Holthe J.E., Goedvolk C.A., Brand R., et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002, 17(12):1032-1037.
44. Akcan-Arikan A., Zappitelli M., Loftis L.L., et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007, 71(10):1028-1035.
45. Plotz F.B., Bouma A.B., van Wijk J.A., et al. Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria. Intensive Care Med 2008, 34(9):1713-1717.
46. Jacobson P., West N., Hutchinson R.J. Predictive ability of creatinine clearance estimate models in pediatric bone marrow transplant patients. Bone Marrow Transplant 1997, 19(5):481-485.
47. Blufpand H.N., Tromp J., Abbink F.C., et al. Cystatin C more accurately detects mildly impaired renal function than creatinine in children receiving treatment for malignancy. Pediatr Blood Cancer 2011, 57(2):262-267.
48. Laskin B.L., Nehus E., Goebel J., et al. Cystatin C-estimated glomerular filtration rate in pediatric autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012, 18(11):1745-1752.
49. Foland J.A., Fortenberry J.D., Warshaw B.L., et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 2004, 32(8):1771-1776.
50. Hayes L.W., Oster R.A., Tofil N.M., et al. Outcomes of critically ill children requiring continuous renal replacement therapy. J Crit Care 2009, 24(3):394-400.
51. Michael M., Kuehnle I., Goldstein S.L. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol 2004, 19(1):91-95.
52. Sutherland S.M., Zappitelli M., Alexander S.R., et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010, 55(2):316-325.
53. Rajasekaran S., Jones D.P., Avent Y., et al. Outcomes of hematopoietic stem cell transplant patients who received continuous renal replacement therapy in a pediatric oncology intensive care unit. Pediatr Crit Care Med 2010, 11(6):699-706.
54. Jacobsohn D.A. Acute graft-versus-host disease in children. Bone Marrow Transplant 2008, 41(2):215-221.
55. Filipovich A.H. Diagnosis and manifestations of chronic graft-versus-host disease. Best Pract Res Clin Haematol 2008, 21(2):251-257.
56. McDonald G.B. Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology 2010, 51(4):1450-1460.
57. Westeneng A.C., Hettinga Y., Lokhorst H., et al. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea 2010, 29(7):758-763.
58. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15(6):825-828.
59. Bacigalupo A. Management of acute graft-versus-host disease. Br J Haematol 2007, 137(2):87-98.
60. Deeg H.J. How I treat refractory acute GVHD. Blood 2007, 109(10):4119-4126.
61. Cahn J.Y., Klein J.P., Lee S.J., et al. Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societé Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 2005, 106(4):1495-1500.
62. Laskin B.L., Goebel J., Davies S.M., et al. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 2011, 118(6):1452-1462.
63. Changsirikulchai S., Myerson D., Guthrie K.A., et al. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol 2009, 4(2):345-353.
64. Siami K., Kojouri K., Swisher K.K., et al. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation 2008, 85(1):22-28.
65. Ho V.T., Cutler C., Carter S., et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005, 11(8):571-575.
66. Ruutu T., Barosi G., Benjamin R.J., et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 2007, 92(1):95-100.
67. Cho B.S., Yahng S.A., Lee S.E., et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation 2010, 90(8):918-926.
68. Carreras E., Diaz-Beya M., Rosinol L., et al. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant 2011, 17(11):1713-1720.
69. Ozkaynak M.F., Weinberg K., Kohn D., et al. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991, 7(6):467-474.
70. Barker C.C., Butzner J.D., Anderson R.A., et al. Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2003, 32(1):79-87.
71. Coppell J.A., Richardson P.G., Soiffer R., et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010, 16(2):157-168.
72. Lee S.H., Yoo K.H., Sung K.W., et al. Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Bone Marrow Transplant 2010, 45(8):1287-1293.
73. Rubbia-Brandt L. Sinusoidal obstruction syndrome. Clin Liver Dis 2010, 14(4):651-668.
74. Peres E., Kintzel P., Dansey R., et al. Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease. Blood Coagul Fibrinolysis 2008, 19(3):203-207.
75. McDonald G.B., Sharma P., Matthews D.E., et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984, 4(1):116-122.
76. Jones R.J., Lee K.S., Beschorner W.E., et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987, 44(6):778-783.
77. McCarville M.B., Hoffer F.A., Howard S.C., et al. Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings. Pediatr Radiol 2001, 31(2):102-105.
78. Kumar S., DeLeve L.D., Kamath P.S., et al. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003, 78(5):589-598.
79. Kashyap A., Wingard J., Cagnoni P., et al. Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality. Biol Blood Marrow Transplant 2002, 8(9):493-500.
80. Tay J., Tinmouth A., Fergusson D., et al. Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007, 13(2):206-217.
81. Haussmann U., Fischer J., Eber S., et al. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy. Haematologica 2006, 91(6):795-800.
82. Rosenthal J., Sender L., Secola R., et al. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation. Bone Marrow Transplant 1996, 18(1):185-191.
83. Schlegel P.G., Haber H.P., Beck J., et al. Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin. Ann Hematol 1998, 76(1):37-41.
84. Khoury H., Adkins D., Brown R., et al. Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?. Bone Marrow Transplant 2000, 25(7):737-743.
85. Richardson P.G., Elias A.D., Krishnan A., et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998, 92(3):737-744.
86. Chopra R., Eaton J.D., Grassi A., et al. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol 2000, 111(4):1122-1129.
87. Richardson P.G., Ho V.T., Cutler C., et al. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions. Biol Blood Marrow Transplant 2013, 19(1 Suppl):S88-S90.
88. Faraci M., Lanino E., Dini G., et al. Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 2002, 59(12):1895-1904.
89. Uckan D., Cetin M., Yigitkanli I., et al. Life-threatening neurological complications after bone marrow transplantation in children. Bone Marrow Transplant 2005, 35(1):71-76.
90. Schmidt K., Schulz A.S., Debatin K.M., et al. CNS complications in children receiving chemotherapy or hematopoietic stem cell transplantation: retrospective analysis and clinical study of survivors. Pediatr Blood Cancer 2008, 50(2):331-336.
91. Nishiguchi T., Mochizuki K., Shakudo M., et al. CNS complications of hematopoietic stem cell transplantation. AJR Am J Roentgenol 2009, 192(4):1003-1011.
92. Saiz A., Graus F. Neurologic complications of hematopoietic cell transplantation. Semin Neurol 2010, 30(3):287-295.
93. Wong R., Beguelin G.Z., de Lima M., et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2003, 122(1):128-134.
94. Won S.C., Kwon S.Y., Han J.W., et al. Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. J Pediatr Hematol Oncol 2009, 31(7):505-508.
95. Barba P., Pinana J.L., Valcarcel D., et al. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2009, 15(11):1439-1446.
96. Heo S., Cho H.J., Jeon I.S. A case of posterior reversible encephalopathy syndrome in a child with myelodysplastic syndrome following allogenic bone marrow transplantation. Pediatr Hematol Oncol 2010, 27(1):59-64.